Gain Therapeutics Inc. (GANX) NASDAQ
$3.39 0.22 (6.94%)
Market Cap: $51.42M
As of 04/23/24 04:00 PM EDT. Market closed.
Gain Therapeutics Inc. (GANX)
NASDAQ
$3.39
0.22 (6.94%)
Market Cap: $51.42M
As of 04/23/24 04:00 PM EDT. Market closed.
Add to Portfolio
gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
27
Address
.
PRICE CHART FOR GAIN THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.08
Previous Close
$3.17
Days Range
$3.07 - $3.39
52 week range
$2 - $5.65
Volume
66,437
Avg. Volume (30 days)
94,423
Market Cap
$51.42M
Dividend Yield
-
P/E
(2.31)
Shares Outstanding
16,219,709
Open
$3.08
Previous Close
$3.17
Days Range
$3.07 - $3.39
52 week range
$2 - $5.65
Volume
66,437
Avg. Volume (30 days)
94,423
Market Cap
$51.42M
Dividend Yield
-
P/E
(2.31)
Shares Outstanding
16,219,709
FINANCIAL STATEMENTS FOR GAIN THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GAIN THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Riley Jeffrey Scott | Director | Mar 28, 2024 | Buy | $3.86 | 30,000 | 115,770 | 30,000 | Apr 01, 2024, 04:01 PM |
| Alder Matthias | Chief Executive Officer | Mar 26, 2024 | Option Exercise | $4.06 | 6,085 | 24,705 | 21,140 | Mar 28, 2024, 09:00 PM |
| Alder Matthias | Chief Executive Officer | Dec 21, 2023 | Sale | $2.46 | 206 | 507 | 5,286 | Dec 22, 2023, 04:17 PM |
| Alder Matthias | Chief Executive Officer | Dec 07, 2023 | Sale | $2.50 | 1,820 | 4,550 | 4,855 | Dec 14, 2023, 04:01 PM |
| RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | May 25, 2022 | Buy | $2.58 | 2,482 | 6,404 | 217,729 | May 27, 2022, 04:10 PM |
| RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | May 20, 2022 | Buy | $2.83 | 9,256 | 26,194 | 215,247 | May 23, 2022, 04:41 PM |
| RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | May 19, 2022 | Buy | $2.71 | 4,000 | 10,840 | 205,991 | May 23, 2022, 04:41 PM |
| Calabrese Salvatore | CHIEF FINANCIAL OFFICER | May 19, 2022 | Buy | $2.70 | 3,000 | 8,100 | 3,000 | May 23, 2022, 04:00 PM |
| Calabrese Salvatore | CHIEF FINANCIAL OFFICER | May 19, 2022 | Buy | $8100.00 | 3,000 | 24,300,000 | 8,100 | May 19, 2022, 05:00 PM |
| RICHMAN ERIC I | Chief Executive Officer | Aug 16, 2021 | Buy | $7.87 | 4,922 | 38,716 | 216,820 | Apr 21, 2022, 04:50 PM |
| RICHMAN ERIC I | Director | Aug 16, 2021 | Option Exercise | $7.87 | 4,922 | 38,716 | 216,820 | Aug 17, 2021, 09:03 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Riley Jeffrey Scott | Director | 03/28/2024 | 115,770 |
| Alder Matthias | Chief Executive Officer | 03/26/2024 | 24,705 |
| Alder Matthias | Chief Executive Officer | 12/21/2023 | 507 |
| Alder Matthias | Chief Executive Officer | 12/07/2023 | 4,550 |
| RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | 05/25/2022 | 6,404 |
| RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | 05/20/2022 | 26,194 |
| RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | 05/19/2022 | 10,840 |
| Calabrese Salvatore | CHIEF FINANCIAL OFFICER | 05/19/2022 | 8,100 |
| Calabrese Salvatore | CHIEF FINANCIAL OFFICER | 05/19/2022 | 24,300,000 |
| RICHMAN ERIC I | Chief Executive Officer | 08/16/2021 | 38,716 |
| RICHMAN ERIC I | Director | 08/16/2021 | 38,716 |
Load More Insider Transactions
FUNDS WITH A POSITION IN GAIN THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GREENLIGHT CAPITAL INC | 588,410 | 0.09% | No change | Activists |
| GEODE CAPITAL MANAGEMENT, LLC | 151,476 | 0.00005% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 42,800 | 0.00022% | -8.74% | Other |
| BLACKROCK INC. | 27,611 | 0% | -1.12% | Other |
CHANGE IN SHARES OUTSTANDING FOR GAIN THERAPEUTICS INC
STOCK BUYBACKS FOR GAIN THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
18.25%
1Q
06/30/2023
21.25%
2Q
03/31/2023
25.84%
3Q
12/31/2022
26.39%
4Q
09/30/2022
26.39%
5Q
06/30/2022
26.39%
6Q
03/31/2022
26.39%
7Q
12/31/2021
26.21%
8Q
09/30/2021
26.46%
9Q
06/30/2021
26.46%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GAIN THERAPEUTICS INC
LOADING...